Needle-Free Diabetes Management Market Drivers, Restraints, and Challenges Shaping the Disposable Medical Device Sensors Market Dynamics | P&S IntelligenceMay 5, 2021
The surging awareness on the safety issues with needles, growing aging population, and massive demand for needle-free treatment devices are driving the growth of the needle-free diabetes management market. In 2016, the market attained a size of $3,830.6 million, and it is predicted to generate revenue of more than $16,800.0 million by 2025. Needle-free diabetes management is a technique of monitoring, diagnosing, and treating a diabetic patient without the use of needles. Such devices are adopted for monitoring the blood glucose level and injecting insulin into diabetic patients.
Request to Get the Sample Pages at:
On the basis of region, the needle-free diabetes management market is classified into Asia-Pacific, Europe, North America, and Rest of the World. Among these, during 2014–2016 (historical period), North America led the market in terms of revenue, and it is projected to continue leading it during 2017–2025, owing to the high prevalence of diabetes, technological advancements, and positive government regulations. In North America, due to the surging geriatric population and prevalence of obesity, diabetes has become one of the major public health issues.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=needle-free-diabetes-management-market
The demand for needle-free diabetes management market is increasing due to increasing prevalence of diabetes. The prevalence of diabetes is increasing due to the alteration in lifestyle and lack of access to preventive care. To reduce the worldwide burden of diabetes, the demand for technologically advanced diabetes management is increasing, which is further expected to increase the demand for needle-free diabetes management devices, as they are easy and safe mode of insulin delivery and blood glucose monitoring.
GLOBAL NEEDLE-FREE DIABETES MANAGEMENT MARKET SEGMENTATION
- Treatment device
o Insulin pen & jet injector
o Insulin patch & pump
o Insulin inhaler
- Diagnostic device
- Artificial pancreas
- North America
o Rest of North America
o Rest of Europe
o Rest of Asia-Pacific
- Rest of the World (RoW)
o Rest of RoW
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]